Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by ventureveston Apr 13, 2010 10:12pm
457 Views
Post# 16988468

Flow through shares

Flow through shares

This  is  likely the  flow  through  shares  that  were  sold   back in  December   being  dumped   as they  became  free  trading.... The   cost  after   tax   benifit   is  in the  3 to 4 cent  range. They   will  likely   dump the  shares  and  ride the  wt  for  exposure to this  play.
The  wts  are  at  .15 so it  is  not the  exercise  of  wts  happening,  it  is the  selling  of the  shares  from that  placement...JMHO

Enjoy it  while it  lasts  as   once   they are  done,  HLO  will  move  back into the   .08 to .10  range.JMHO
 There  won't be  any   selling  presure  from  wt  exercise  untill   HLO  gets into the  .20's... But  this  paper  will  likely  change  hands  repeatedly  on its  way   up..

Filling  my  boots   with  the   cheap  stuff!

Halo Resources 19.95-million-share private placement

2009-12-08 19:16 ET - Private Placement

The TSX Venture Exchange has accepted for filing documentation with respect to the second and final tranche of a brokered private placement announced Sept. 29, 2009, and amended on Oct. 19, 2009.

Number of shares:  19.95 million flow-through shares

Purchase price:  Five cents per share

Warrants:  9,975,000 share purchase warrants to purchase 9,975,000 shares

Warrant exercise price:  15 cents for a one-year period and 20 cents in the second year

Hidden placees:  37 hidden placees

Pro group:  Fred Solmon, 100,000

Agent's fee:  $69,825 and 1,396,500 compensation warrants, exercisable at five cents for a two-year period into one non-flow-through share and one non-flow-through share purchase warrant exercisable at 7.5 cents for the first year and 10 cents for second year, payable to Loewen, Ondaatje, McCutcheon

<< Previous
Bullboard Posts
Next >>